Neuraxis, Inc. (NRXS)
NYSE American · Manufacturing · Electromedical & electrotherapeutic apparatus
$7.57−$0.1800 (−2.32%) on the dayAs of the close; data may be delayed.
NRXS price, last 12 months
Key stats
- Previous close
- $7.75
- Open
- $7.81
- Day range
- $7.57 – $7.99
- 52-week range
- $2.21 – $9.33
- Volume
- 140.8K
- Avg volume (20 days)
- 156.9K
- Market cap
- $94.9M
Performance
1W−0.5%
1M+27.0%
3M+4.1%
6M+8.1%
YTD+66.7%
1Y+181.4%
vs S&P 500, 1Y+164.6 pts
Technicals and fundamentals
About Neuraxis, Inc.
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
- Sector
- Manufacturing
- Industry
- Electromedical & electrotherapeutic apparatus
- Listed on
- NYSE American
- Market cap
- $94.9M